Literature DB >> 27022716

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis.

Juan Pellico1, Jesús Ruiz-Cabello1, Fernando Herranz2.   

Abstract

A fast and reproducible microwave-driven protocol has been developed for the synthesis of neridronate-functionalized nanoparticles. Starting from the synthesis of hydrophobic nanoparticles, our method is based on an adaptation from thermal decomposition method to microwave driven synthesis. The new methodology produces a decrease in the reaction times in comparison with traditional procedures. Moreover, the use of the microwave technology increases the reproducibility of the reactions, something important from the point of view of clinical applications. The novelty of this iron oxide nanoparticle is the attachment of Neridronate. The use of this molecule leads a bisphosphonate moiety towards the outside of the nanoparticle that provides Ca2+ binding properties in vitro and selective accumulation in vivo in the atheroma plaque. The protocol allows the synthesis and plaque detection in about 3 hr since the initial synthesis from organic precursors. Their accumulation in the atherosclerotic area in less than 1 hr provides a contrast agent particularly suitable for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27022716      PMCID: PMC4829051          DOI: 10.3791/53472

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

Review 1.  Multifunctional nanoparticles for multimodal imaging and theragnosis.

Authors:  Dong-Eun Lee; Heebeom Koo; In-Cheol Sun; Ju Hee Ryu; Kwangmeyung Kim; Ick Chan Kwon
Journal:  Chem Soc Rev       Date:  2011-12-21       Impact factor: 54.564

2.  Superparamagnetic iron oxide nanoparticles conjugated to a grass pollen allergen and an optical probe.

Authors:  Fernando Herranz; Carsten B Schmidt-Weber; Mohamed H Shamji; Annemarie Narkus; Jesus Ruiz-Cabello; Ramon Vilar
Journal:  Contrast Media Mol Imaging       Date:  2012 Jul-Aug       Impact factor: 3.161

3.  A new method for the aqueous functionalization of superparamagnetic Fe2O3 nanoparticles.

Authors:  Fernando Herranz; Ma Puerto Morales; Alejandro G Roca; Ramón Vilar; Jesús Ruiz-Cabello
Journal:  Contrast Media Mol Imaging       Date:  2008 Nov-Dec       Impact factor: 3.161

Review 4.  Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications.

Authors:  Meng Meng Lin; Do Kyung Kim; Alicia J El Haj; Jon Dobson
Journal:  IEEE Trans Nanobioscience       Date:  2008-12       Impact factor: 2.935

5.  A new method for the rapid synthesis of water stable superparamagnetic nanoparticles.

Authors:  Fernando Herranz; M Puerto Morales; Alejandro G Roca; Manuel Desco; Jesús Ruiz-Cabello
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

6.  Rapid synthesis of water-dispersible superparamagnetic iron oxide nanoparticles by a microwave-assisted route for safe labeling of endothelial progenitor cells.

Authors:  Elisa Carenza; Verónica Barceló; Anna Morancho; Joan Montaner; Anna Rosell; Anna Roig
Journal:  Acta Biomater       Date:  2014-04-20       Impact factor: 8.947

Review 7.  Treatment of bone diseases with bisphosphonates, excluding osteoporosis.

Authors:  J P Devogelaer
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

8.  Size-controlled synthesis of magnetite nanoparticles.

Authors:  Shouheng Sun; Hao Zeng
Journal:  J Am Chem Soc       Date:  2002-07-17       Impact factor: 15.419

Review 9.  Bisphosphonates: mechanism of action and role in clinical practice.

Authors:  Matthew T Drake; Bart L Clarke; Suneep Khosla
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616

10.  Clinical development of neridronate: potential for new applications.

Authors:  Davide Gatti; Maurizio Rossini; Ombretta Viapiana; Luca Idolazzi; Silvano Adami
Journal:  Ther Clin Risk Manag       Date:  2013-04-03       Impact factor: 2.423

View more
  1 in total

1.  A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis.

Authors:  Samuel Bonnet; Geoffrey Prévot; Stéphane Mornet; Marie-Josée Jacobin-Valat; Yannick Mousli; Audrey Hemadou; Mathieu Duttine; Aurélien Trotier; Stéphane Sanchez; Martine Duonor-Cérutti; Sylvie Crauste-Manciet; Gisèle Clofent-Sanchez
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.